These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 23680667
1. Quantitative computed tomography assessment of bone mineral density after 2 years' oral bisphosphonate treatment in postmenopausal osteoarthritis patients who underwent total knee arthroplasty. Lee JK, Choi CH, Kang CN. J Int Med Res; 2013 Jun; 41(3):878-88. PubMed ID: 23680667 [Abstract] [Full Text] [Related]
4. Effect of one-year post-operative alendronate treatment on periprosthetic bone after total knee arthroplasty. A seven-year randomised controlled trial of 26 patients. Jaroma AV, Soininvaara TA, Kröger H. Bone Joint J; 2015 Mar; 97-B(3):337-45. PubMed ID: 25737517 [Abstract] [Full Text] [Related]
6. Effect of alendronate on periprosthetic bone loss after total knee arthroplasty: a one-year, randomized, controlled trial of 19 patients. Soininvaara TA, Jurvelin JS, Miettinen HJ, Suomalainen OT, Alhava EM, Kröger PJ. Calcif Tissue Int; 2002 Dec; 71(6):472-7. PubMed ID: 12370800 [Abstract] [Full Text] [Related]
8. Teriparatide Administration Increases Periprosthetic Bone Mineral Density After Total Knee Arthroplasty: A Prospective Study. Suzuki T, Sukezaki F, Shibuki T, Toyoshima Y, Nagai T, Inagaki K. J Arthroplasty; 2018 Jan; 33(1):79-85. PubMed ID: 28869116 [Abstract] [Full Text] [Related]
9. The relationship of bone density and fracture to incident and progressive radiographic osteoarthritis of the knee: the Chingford Study. Hart DJ, Cronin C, Daniels M, Worthy T, Doyle DV, Spector TD. Arthritis Rheum; 2002 Jan; 46(1):92-9. PubMed ID: 11817613 [Abstract] [Full Text] [Related]
10. Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis. Keaveny TM, Donley DW, Hoffmann PF, Mitlak BH, Glass EV, San Martin JA. J Bone Miner Res; 2007 Jan; 22(1):149-57. PubMed ID: 17042738 [Abstract] [Full Text] [Related]
11. The use of bone turnover markers for monitoring the treatment of osteoporosis in postmenopausal females undergoing total knee arthroplasty: a prospective randomized study. Ma R, Wu M, Li Y, Wang J, Yang P, Chen Y, Wang W, Song J, Wang K. J Orthop Surg Res; 2021 Mar 17; 16(1):195. PubMed ID: 33731168 [Abstract] [Full Text] [Related]
12. Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): additional results from the Monthly Oral Therapy With Ibandronate For Osteoporosis Intervention (MOTION) study. Emkey R, Delmas PD, Bolognese M, Borges JL, Cosman F, Ragi-Eis S, Recknor C, Zerbini CA, Neate C, Sedarati F, Epstein S. Clin Ther; 2009 Apr 17; 31(4):751-61. PubMed ID: 19446148 [Abstract] [Full Text] [Related]
13. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis. Gallagher JC, Rosen CJ, Chen P, Misurski DA, Marcus R. Bone; 2006 Dec 17; 39(6):1268-75. PubMed ID: 16884968 [Abstract] [Full Text] [Related]
14. A comparison of the effects of alendronate and alfacalcidol on bone mineral density around the femoral implant and in the lumbar spine after total hip arthroplasty. Iwamoto N, Inaba Y, Kobayashi N, Ishida T, Yukizawa Y, Saito T. J Bone Joint Surg Am; 2011 Jul 06; 93(13):1203-9. PubMed ID: 21776573 [Abstract] [Full Text] [Related]
15. Assessment of vertebral fracture risk and therapeutic effects of alendronate in postmenopausal women using a quantitative computed tomography-based nonlinear finite element method. Imai K, Ohnishi I, Matsumoto T, Yamamoto S, Nakamura K. Osteoporos Int; 2009 May 06; 20(5):801-10. PubMed ID: 18800178 [Abstract] [Full Text] [Related]
16. Postoperative Stiffness Requiring Manipulation Under Anesthesia Is Significantly Reduced After Simultaneous Versus Staged Bilateral Total Knee Arthroplasty. Meehan JP, Monazzam S, Miles T, Danielsen B, White RH. J Bone Joint Surg Am; 2017 Dec 20; 99(24):2085-2093. PubMed ID: 29257014 [Abstract] [Full Text] [Related]
17. The effect of vitamin D receptor BsmI genotype on the response to osteoporosis treatment in postmenopausal women: a pilot study. Creatsa M, Pliatsika P, Kaparos G, Antoniou A, Armeni E, Tsakonas E, Panoulis C, Alexandrou A, Dimitraki E, Christodoulakos G, Lambrinoudaki I. J Obstet Gynaecol Res; 2011 Oct 20; 37(10):1415-22. PubMed ID: 21651652 [Abstract] [Full Text] [Related]
18. Posterior Cruciate Ligament Retention or Substitution During Total Knee Arthroplasty Does Not Affect Long-Term Bone Mineral Density or Quality. Ishii Y, Noguchi H, Sato J, Todoroki K, Toyabe SI. J Arthroplasty; 2017 Apr 20; 32(4):1148-1152. PubMed ID: 27856067 [Abstract] [Full Text] [Related]
19. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy. Kendler DL, Roux C, Benhamou CL, Brown JP, Lillestol M, Siddhanti S, Man HS, San Martin J, Bone HG. J Bone Miner Res; 2010 Jan 20; 25(1):72-81. PubMed ID: 19594293 [Abstract] [Full Text] [Related]
20. Gait parameters in women with bilateral osteoarthritis after unilateral versus sequential bilateral total knee arthroplasty. Mine T, Ihara K, Kawamura H, Kuriyama R, Date R. J Orthop Surg (Hong Kong); 2015 Apr 20; 23(1):76-9. PubMed ID: 25920650 [Abstract] [Full Text] [Related] Page: [Next] [New Search]